The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized ...
Vyvgart Hytrulo treats generalized myasthenia gravis (gMG), a neuromuscular disorder, and chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disorder affecting nerves. It’s given ...
The U.S. Food and Drug Administration has approved Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) subcutaneous injections for the treatment of generalized myasthenia gravis (gMG) in adult ...
How Do Vyvgart & Vyvgart Hytrulo Work in gMG? gMG is an autoimmune disease where the immune system mistakenly damages the connections between your nerves and muscles. This weakens your muscles and ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results